Immunocellular(美國(guó))

Immunocellular

美國(guó)ImmunoCellularTherapeuticswww.imuc.comIMUC是一家總部位于洛杉磯的臨床階段公司，致力于開(kāi)發(fā)免疫療法來(lái)治療腦癌和其它癌癥。該公司的先導(dǎo)候選產(chǎn)品ICT-107最近進(jìn)入II期試驗(yàn)，ICT-107是一種基于樹(shù)突狀細(xì)胞的疫苗，該疫苗以多個(gè)腫瘤相關(guān)抗原為靶向，用于治療新診斷出的膠質(zhì)母細(xì)胞瘤。Ourmissionistoimprovecancertreatmentan ddiagnosisthroughthediscoveryanddevelopmentofnewimmune-basedproducts.Designedtoharnessbotharmsofthenativeimmunesystem,ourpipelineincludesbothactiveimmunotherapiesandpatentedmonoclonalantibodies(mABs).Ouractiveimmunotherapiestargetnotonlyregulartumorcells,butalsothecancerstemcellsbelievedtocausecancergrowthandrecurrence.Ourmostadvancedclinicalprogramsareinglioblastomamultiforme(GBM),butourtechnologieshavepotentialapplicationsinmanycancerswithhighunmetmedicalneed,includingpancreatic,ovarian,colon,small-celllung,andmultiplemyeloma.OurleadproductcandidateisICT-107,apersonalized,dendriticcell-basedvaccineforthetreatmentofGBM.Weintendtoinitiate